So you didn't read the study then? That's the reason I posted it as a response to an actual absurd post. Seems most think that either zero placebo patients can remain above baseline, zero competitor drugs produce any patients that remain above baseline for any period of time, or didn't even realize the current trial includes patients on other AD drugs as part of the placebo group. Talk about absurd!
Market Data 
Markets 
AI
